Effect of Cisapride on Myoelectrical Activity of the Gastrointestinal Tract in the Conscious Miniature Pig

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 45, Issue 2, 1998, Pages 63-68

  Wechsung, E ^a,b   Houvenaghel, A ^a,b  

^a University Centre of Antwerp ^*  (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SUS SCROFA;

EID: 2742559795     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.1998.tb00801.x     Document Type: Article

References (28)

1. BRIEJER, M. R , L. M. AKERMANS, and J. A. J. SCHUURKES, 1995: Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol. Rev. 47, 631-651.
2. DOWLING, P. M., 1995: Prokinetic drugs: metoclopramide and cisapride. Can. Vet. J. 36, 115-116.
3. EDELBROEK, M., J. SCHUURKES, W. DE RIDDER, M. HOROWITZ, J. DENT, and L. AKKERMANS, 1995: Effect of cisapride on myoelectrical and motor responses of antropyloroduodenal region during intraduodenal lipid and antral tachygastria in conscious dog. Dig. Dis. Sci. 40, 901-911.
4. 4 receptor antagonists. Med. Res. Rev. 17, 163-214.
5. GREGORY, P. C., M. MCFAYDEN, and D. V. RAYNER, 1995: Control of gastric emptying in the pig: influence of cholecystokinin, somatostatin and prokinetic agents. Exp. Phsyiol. 80, 159-165
6. GULLIKSON, G. W., R. F. LOEFLER, and M. A. VIRINA, 1991. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. J. Pharmacol. Exp. Therap. 258, 103-110.
7. 4 receptor mechanism. J. Pharmacol. Exp. Therap. 264, 240-248.
8. HEBBARD, G. H., W. M. SUN, F. BOCHNER, M. HOROWITZ, 1995: Pharmakinetic considerations in gastrointestinal motor disorders. Clin. Pharmacokinet. Dis. Proc. 28, 41-66.
9. HOROWITZ, M., and R. J. L. FRASER, 1995: Gastroparesis: diagnosis and management. Scand. J. Gastroenterol. 30, (suppl. 273), 7-16
10. HOROWITZ, M., A. MADDOX, P. E. HARDING, G. J. MADDERN, B E. CHATTERTON, J. WISHART, and D. J. C. SHEARMAN, 1987: Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 92, 1899-1907.
11. LUX, G., M. KATSCHINSKI, S. LUDWIG, P. LEDERER, A. ELLERMAN, and W. DOMSCHKE, 1994: The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility. Scand. J. Gastroenterol, 29, 1105-1110.
12. MCCALLUM, R. W., C. PRAKASH, D. M. CAMPOLI-RICHARDS, and K. L. GOA, 1988: Cisapride, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36, 652-681.
13. MCHUGH, S, S. LICO, and N. E. DIAMANT, 1992: Cisapride vs. metoclopramide. An acute study in diabetic gastroparesis. Dig Dis. Sci. 37, 997-1001.
14. MEGENS, A. A. H. P., F. H. L. AWOUTERS, and C. J. E. NIEMEGEERS, 1991: General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Drug Res. 41, 631-634.
15. NAGAKURA, N., K.-Y. SOHDA, H. ITO, and K. MIYATA, 1997: Gastrointestinal motor activity in conscious ferrets. Eur. J. Pharmacol. 321, 53-57.
16. ONAT, F., B. YEGEN, K BERKMAN, and S. OKTAY, 1994: The hypotensive effect of cisapride in rat. Gen. Pharmacol. 25, 1253-1256.
17. ORIHATA, M., and S. K. SARNA, 1994: Contractile mechanisms of action of gastroprokinetic agents cisapride, metoclopramide, and domperidone. Am. J. Physiol. 266, G665-G667.
18. SCHUURKES, J. A. J., L. M. A. AKKERMAN, and J. M. VAN NUETEN, 1984: Stimulating effects of cisapride in antroduodenal motility in the conscious dog. In: ROMAN, C. (ed.), Proceedings of the Ninth International Symposium on GI Motility, Aix-en-Provence, France. MTP Press, Lancaster. pp. 95-102.
19. SCHUURKES, J. A. J., J. M. VAN NUETEN, P. G. H. VAN DAELE, A. J. REYNTJENS, and P. A. J. JANSSEN , 1985: Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J. Pharmacol. Exp. Ther. 234, 775-783.
20. STACHER, G., H. STEINRINGER, C. SCHNEIDER, S. WINKLEHNER, G. MITTELBACH, and G. GAUPMANN, 1986: Effects of cisapride on jejunal motor activity in fasting healthy humans. Gastroenterology 90, 1210-1216.
21. TALLEY, N. J., 1992: Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 6, 273-289.
22. TONINI, M., 1996: Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol. Res. 33, 217-225.
23. VAEZI, M. F., R. SEARS, and J. E. RICHTER, 1996: Placebo-controlled trial of cisapride, in postgastrectomy patients with duodenogastroesophageal reflux. Dig. Dis. Sci. 41, 754-763.
24. VOLMER, P. A., 1996: Cisapride toxicosis in dogs. Vet. Hum. Toxicol. 38, 118-120.
25. WASHABAU, R. J., and J. A. HALL, 1995: Cisapnde. J. Am. Vet. Med. Assoc. 207, 1285-1288.
26. WECHSUNG, E., and A. HOUVENAGHEL, 1993: Effect of serotonin on gastrointestinal electrical activity in the conscious piglet. J. Vet. Med. A. 40, 533-538.
27. WECHSUNG, E., and A. HOUVENAGHEL, 1995: Effect of CCK-8 on myoelectrical activity of the gastrointestinal tract in the conscious miniature pig. Peptides 16, 1429-1432
28. WECHSUNG, E., and A. HOUVENAGHEL, 1997: Effect of cisapride on myoelectrical activity of the antrum pylon in the conscious miniature pig. J. Vet. Pharmacol. Therap. 20, 323-325.